ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,160,000 | -8.9% | 70,900 | +34.8% | 0.02% | -20.0% |
| Q1 2022 | $1,274,000 | -5.1% | 52,611 | -8.6% | 0.02% | -28.6% |
| Q4 2021 | $1,343,000 | -7.8% | 57,560 | -3.6% | 0.04% | +29.6% |
| Q2 2021 | $1,456,000 | +52.6% | 59,698 | +61.5% | 0.03% | +68.8% |
| Q1 2021 | $954,000 | -70.6% | 36,976 | -53.0% | 0.02% | -83.5% |
| Q3 2020 | $3,242,000 | -14.9% | 78,600 | 0.0% | 0.10% | -46.7% |
| Q2 2020 | $3,810,000 | – | 78,600 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |